|
|
Post by afrizzle on Dec 19, 2015 18:52:36 GMT -5
I don't understand how massive short covering could be happening without a corresponding massive price rise. Therefore, unless someone can educate me as to how this is possible I'm stuck believing the short covering is not happening in a big way
|
|
|
|
Post by inittowinit on Dec 19, 2015 19:31:34 GMT -5
LOVE the homage to KBall!  |
|
|
|
Post by sccrbrg on Dec 19, 2015 19:55:36 GMT -5
I don't understand how massive short covering could be happening without a corresponding massive price rise. Therefore, unless someone can educate me as to how this is possible I'm stuck believing the short covering is not happening in a big way It's pretty easy when they utilize options or there's more people selling than buying (like when index funds rebalance). IMO they've got a stranglehold on this stock and this has been the game plan all along. I highly doubt we see a short squeeze. Best case news forces an organized covering and we see more funds go long and the price appreciates. |
|
|
|
Post by jpg on Dec 19, 2015 20:08:47 GMT -5
I don't understand how massive short covering could be happening without a corresponding massive price rise. Therefore, unless someone can educate me as to how this is possible I'm stuck believing the short covering is not happening in a big way Easy: shareholders are giving up and selling. Massive coveringmaybe not but covering no less. The new equilibrium is now around 600 million market cap. I suspect this is extraordinarily cheap but I only have 1/5 of my peak stake because there is so little info and clarity. Only certainty Sanofi will stick around and a rising script count will personally give me the clarity I need to buy more. I suspect I am not alone... |
|
|
|
Post by mssciguy on Dec 19, 2015 20:25:52 GMT -5
jpg was at the library today and scoured the magazines for ads, saw only one, in Cooking Light, for December. 20:1 outnumbered in the magazines by other diabetes meds at the small local library I frequent. the Sanofi/MNKD secrecy agreement is so insulting to retail shareholders. Obviously GSCO and the hedge funds knew the whole trajectory and played it like a grand piano, while thousands complained to SEC (which remained silent of course, being the tool of Wall Street). Should we be comforted by the completely linear refill Rx growth? It's very strange, almost controlled. Time will tell. I sure wish that there was an anti-anxiety TS application, and that retail shareholders could be part of Phase I, II, and III. And maybe beyond.... come on, Al, you don't have the f'ing punk to worry about anymore, let's see some action.
|
|
|
|
Post by suebeeee1 on Dec 19, 2015 20:57:11 GMT -5
Lucky us. MNKD gets FDA approved and the shorts squeeze the longs. MNKD partners with SNY and the shorts squeeze the longs. The shorts interest ends up over 50% and then WE have a short squeeze without a squeeze!
Only MNKD! Someday we longs will catch a break.
|
|
|
|
Post by purge on Dec 19, 2015 21:08:03 GMT -5
Has anyone ever been in a stock where everything is constantly bizarro world? Bizarro code has been in effect long enough here at DKNM.
|
|
|
|
Post by afrizzle on Dec 20, 2015 7:39:29 GMT -5
I don't understand how massive short covering could be happening without a corresponding massive price rise. Therefore, unless someone can educate me as to how this is possible I'm stuck believing the short covering is not happening in a big way Easy: shareholders are giving up and selling. Massive coveringmaybe not but covering no less. The new equilibrium is now around 600 million market cap. I suspect this is extraordinarily cheap but I only have 1/5 of my peak stake because there is so little info and clarity. Only certainty Sanofi will stick around and a rising script count will personally give me the clarity I need to buy more. I suspect I am not alone... I understand the downward trajectory. Longs are despondent and either reluctant to buy when the price goes on sale, are fed up with the manipulation and losing hope, or are simply out of dry powder. I'm personally in the camp that's reluctant to go deeper regardless of how low the price goes - but I won't sell i still struggle to see how 120 million short shares, some of which may not actually exist, get reconciled without significant upward price movement. If someone would kindly explain the way to avoid this with option play, in a bit more detail, I'd appreciate it. |
|
|
|
Post by jpg on Dec 20, 2015 9:07:13 GMT -5
Easy: shareholders are giving up and selling. Massive coveringmaybe not but covering no less. The new equilibrium is now around 600 million market cap. I suspect this is extraordinarily cheap but I only have 1/5 of my peak stake because there is so little info and clarity. Only certainty Sanofi will stick around and a rising script count will personally give me the clarity I need to buy more. I suspect I am not alone... I understand the downward trajectory. Longs are despondent and either reluctant to buy when the price goes on sale, are fed up with the manipulation and losing hope, or are simply out of dry powder. I'm personally in the camp that's reluctant to go deeper regardless of how low the price goes - but I won't sell i still struggle to see how 120 million short shares, some of which may not actually exist, get reconciled without significant upward price movement. If someone would kindly explain the way to avoid this with option play, in a bit more detail, I'd appreciate it. I personally don't see how options can be used by shorts to 'escape' if things go well. Who would take the other side of the trade? Only dilution or outright failure will unwind this elegantly for the shorts. |
|
|
|
Post by bretzyboy on Dec 20, 2015 9:38:37 GMT -5
The contract is exercised to buy the shares, the shares are used to cover the short, bada bing. The entire transaction takes about 15.5 milliseconds.
|
|
|
|
Post by monetpenet on Dec 20, 2015 9:58:57 GMT -5
I understand the downward trajectory. Longs are despondent and either reluctant to buy when the price goes on sale, are fed up with the manipulation and losing hope, or are simply out of dry powder. I'm personally in the camp that's reluctant to go deeper regardless of how low the price goes - but I won't sell i still struggle to see how 120 million short shares, some of which may not actually exist, get reconciled without significant upward price movement. If someone would kindly explain the way to avoid this with option play, in a bit more detail, I'd appreciate it. I personally don't see how options can be used by shorts to 'escape' if things go well. Who would take the other side of the trade? Only dilution or outright failure will unwind this elegantly for the shorts.
Anything is possible... And can be pre-arranged.
Somebody might have been allowed to make enough illegal profits by now, to be able to take the 'other side of the trade' at certain point.
|
|
|
|
Post by mssciguy on Dec 20, 2015 10:40:34 GMT -5
I personally don't see how options can be used by shorts to 'escape' if things go well. Who would take the other side of the trade? Only dilution or outright failure will unwind this elegantly for the shorts.
Anything is possible... And can be pre-arranged.
Somebody might have been allowed to make enough illegal profits by now, to be able to take the 'other side of the trade' at certain point.
It's felt like a crime scene for quite a while. Schwab interest rate said to be down to 12% now prntscr.com/9gfa46 |
|
|
|
Post by factspls88 on Dec 20, 2015 18:14:32 GMT -5
So.... does anyone remember when Matt said that the manipulation was "not so innocent" ? Freaking ey, a whole book could be written about what's happened with Mannkind, I wonder if anyone's at work on that... Shkreli craves notoriety. Out of sight, out of mind in jail won't do for him. Maybe he will be writing his tell-all autobiography of his short (pun intended) Wall Street adventure during his spare time in the federal country club for white collar criminals. MNKD should deserve at least a chapter of its own. Maybe he'll hatch a crowd funding scheme to publish the book. Come to think of it, if the the book names names and provides enough detail, I might sell some MNKD next year at 5 or 6 to make a contribution. A book wouldn't suit Shkreli. It'd more likely be rap video or movie a la Eight Mile.  |
|
|
|
Post by compound26 on Dec 21, 2015 10:47:18 GMT -5
jpg was at the library today and scoured the magazines for ads, saw only one, in Cooking Light, for December. 20:1 outnumbered in the magazines by other diabetes meds at the small local library I frequent. the Sanofi/MNKD secrecy agreement is so insulting to retail shareholders. Obviously GSCO and the hedge funds knew the whole trajectory and played it like a grand piano, while thousands complained to SEC (which remained silent of course, being the tool of Wall Street). Should we be comforted by the completely linear refill Rx growth? It's very strange, almost controlled. Time will tell. I sure wish that there was an anti-anxiety TS application, and that retail shareholders could be part of Phase I, II, and III. And maybe beyond.... come on, Al, you don't have the f'ing punk to worry about anymore, let's see some action. I can confirm that there is Aferzza ad in the December 2015 issue of the Good Housekeeping. I have a copy of that issue. However, if you did not see the ad, it could be the ad was run regionally. |
|
|
|
Post by mssciguy on Dec 21, 2015 11:01:46 GMT -5
compound26 It could be that ads are regional. FWIW delivery of magazines to this area runs a little late, so it could be that major urban areas are served first (and ergo might merit higher ad fees). Never considered that before, thanks! Over the weekend, I pored over the 2016 Old Farmers Almanac. You would not believe some of the ads in there. No prescription drug ads but I'd bet that advertising something like Afrezza to the rural population in some way would be huge. Think about it, nobody wants to drive 70 miles to "town" just because their pen or liquid insulin went bad. That would not happen with Afrezza...
|
|
